Teosyal® Pure Sense Ultra Deep

Teosyal® Pure Sense Ultra Deep

Teosyal® Pure Sense Ultra Deep is the second most intense treatment of the Teosyal® range. Although one of the most expensive in the range, it is also one of the most dramatic and long lasting and is specifically designed for the use in treatments involving a high amount of volume. It is also Teosyals’ densest product so is capable of achieving impressive effects.

The main uses of Teosyal® Ultra Deep is to create an restore facial volumes, treat especially deep wrinkles in thicker skin, re-sculpt facial contours, eradicate any folds in the skin and restore original curves found in the face. Even though this is one of the most dramatically effective products available, the injections of Ultra Deep do not require an incision, and are not traumatic to the patient. This means that the pain inflicted by the treatment will be generally similar to that of the other treatments – essentially minimal, whilst still achieving an impressive transformation.

Due to the density and purpose of this product, it can only be injected directly into the deep dermis. As Teosyal® Ultra Deep is injected very deep into the dermis, is the densest of all the Teosyal® products, and has to be injected in sufficient doses (usually larger than the amount injected with other Teosyal® products), it is one of the longest lasting facial fillers available.

Teosyal® Ultra Deep can last up to 12 months on average, so is a very long lasting result. As with all the Teosyal® products, if you wish to maintain the effects of Ultra Deep then a top up will be required around 9 – 12 months after your initial treatment, depending on each individual person.

  • restore the volume of the face,
  • re-sculpt facial contours,
  • fill and smooth deep wrinkles,
  • eliminate folds,
  • restore original curves found in the face

Hyaluronic Acid: 25 mg/ml

Lidocaine: 0,3%


2 x 1,2 ml prefilled syringe

needles: 2 x 27G 1/2 "ultra thin wall"

  • hypersensitivity to one of the components,
  • skin infection near the site of injection,
  • patients susceptible to keloid formation,
  • pregnant or lactating women,
  • allergy or anaphylaxis,
  • bleeding disorders,
  • autoimmune disorders,
  • antibiotic therapy.
Request information

Good Union Corporation Limited
28/F, Easy Tower
609-611 Tai Nan West Street,Cheung Sha Wan, Hong Kong

T: +852 3188 3268
F: +852 3188 2505
E: enquiry@goodunion.com.hk